US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Alprostadil Injection USP

Reason Lack of Assurance of Sterility

Teva Pharmaceuticals USA NDC 0703-1501-02 D-0742-2021
Class II · Moderate risk Terminated

Metoclopramide Injection USP

Reason Lack of Assurance of Sterility

Teva Pharmaceuticals USA NDC 0703-4502-01 D-0741-2021
Class II · Moderate risk Terminated

Adenosine Injection

Reason Lack of Assurance of Sterility

Teva Pharmaceuticals USA NDC 0703-8776-01 D-0740-2021
Class II · Moderate risk Terminated

Norepinephrine Bitartrate Injection

Reason Lack of Assurance of Sterility

Teva Pharmaceuticals USA NDC 0703-1153-03 D-0739-2021
Class II · Moderate risk Terminated

Epoprostenol Sodium for Injection

Reason Lack of Assurance of Sterility

Teva Pharmaceuticals USA NDC 0703-1995-01 D-0738-2021
Class II · Moderate risk Terminated

Leucovorin Calcium for Injection

Reason Lack of Assurance of Sterility

Teva Pharmaceuticals USA NDC 0703-5145-01 D-0737-2021
Class II · Moderate risk Terminated

GaviLyteTM - C PEG-3350

Reason Failed Stability Specification; Out of specification for Osmolarity

Novel Laboratories, Inc. d.b.a LUPIN NDC 43386-060-19 D-0726-2021
Class II · Moderate risk Terminated

Ethosuximide Oral Solution USP 250 mg/5 mL

Reason Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.

PAI Holdings, LLC. dba Pharmaceutical Associates Inc NDC 0121-0670-16 D-0723-2021
Class II · Moderate risk Terminated

Cimetidine Hydrochloride Oral Solution 300 mg/5 mL

Reason Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.

PAI Holdings, LLC. dba Pharmaceutical Associates Inc NDC 0121-0649-08 D-0722-2021
Class II · Moderate risk Terminated

Nystatin Oral Suspension

Reason Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.

PAI Holdings, LLC. dba Pharmaceutical Associates Inc NDC 0121-0868-16 D-0721-2021
Class II · Moderate risk Terminated

Venlafaxine Tablets

Reason Presence of Forein Tablets/Capsules; Venlafaxine Tablets, USP 37.5 mg found in bottles labeled as Venlafaxine Tablets, USP, 50 mg

Sun Pharmaceutical Industries INC NDC 16714-657-01 D-0703-2021
Class II · Moderate risk Terminated

GoodSense Aller.Ease

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 0113-0571-30 D-0357-2022
Class II · Moderate risk Terminated

CVS Allergy Relief

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 69842-698-39 D-0356-2022
Class II · Moderate risk Terminated

Kirkland Aller-Fex

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 63981-571-48 D-0355-2022
Class II · Moderate risk Terminated

amazon basic+care

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 72288-425-78 D-0354-2022
Class II · Moderate risk Terminated

Wal-Fex Fexofenadine Hydrochloride tablets

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 0363-0903-62 D-0353-2022